Published in Eur J Epidemiol on June 01, 2000
Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancer. Gut (2002) 0.83
Timing of blood extraction in epidemiologic and proteomic studies: results and proposals from the PANKRAS II Study. Eur J Epidemiol (2007) 0.81
Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients. Eur J Epidemiol (2011) 0.81
A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma. Int J Proteomics (2015) 0.79
Estimating dietary intakes from a brief questionnaire: A simulation study of reliability in a molecular epidemiologic study of pancreatic and biliary diseases. Eur J Epidemiol (2006) 0.76
Autopsy diagnoses of malignant neoplasms: how often are clinical diagnoses incorrect? JAMA (1998) 9.21
Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg (1996) 4.51
Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group. J Epidemiol Community Health (1999) 4.43
Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst (1994) 1.73
Pancreatic carcinoma. Lancet (1997) 1.72
Epidemiology: bridges over (and across) roaring levels. J Epidemiol Community Health (1998) 1.69
Estimating the effects of misclassification. Lancet (1993) 1.57
Occupational exposures and pancreatic cancer: a meta-analysis. Occup Environ Med (2000) 1.56
Diagnosis of pancreatic carcinoma. Imaging techniques and tumor markers. Pancreas (1992) 1.53
Diagnostic certainty and potential for misclassification in exocrine pancreatic cancer. PANKRAS I Project Investigations. J Clin Epidemiol (1994) 1.50
Occurrence, trends and environment etiology of pancreatic cancer. Scand J Work Environ Health (1998) 1.38
Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group. Lancet (2000) 1.11
Long-term survival after pancreatic adenocarcinoma--often a misdiagnosis? Br J Cancer (1993) 0.96
Coffee, pancreatic cancer, and K-ras mutations: updating the research agenda. J Epidemiol Community Health (2000) 0.96
Learning from case reports: diagnostic issues in an epidemiologic study of pancreatic cancer. J Clin Epidemiol (1998) 0.95
Pancreatic and biliary endoscopy. N Engl J Med (1999) 0.91
Risk of pancreatic cancer and occupational exposures in Spain. PANKRAS II Study Group. Ann Occup Hyg (2000) 0.87
Diagnostic certainty in pancreatic cancer. J Clin Epidemiol (1996) 0.86
DDT and pancreatic cancer. J Natl Cancer Inst (1993) 0.85
Uncertainty in the diagnosis of histologically confirmed pancreatic cancer cases. Int J Epidemiol (1989) 0.83
Medical conditions in patients with pancreatic and biliary diseases: validity and agreement between data from questionnaires and medical records. PANKRAS II Study Group. Dig Dis Sci (1999) 0.82
Pancreatic adenocarcinoma: an update. J Am Coll Surg (1996) 0.81
Diagnostic workup of patients with suspected pancreatic carcinoma: the University of California-Los Angeles approach. Cancer (1997) 0.81
Workup of a patient with a mass in the head of the pancreas. Pancreas (1998) 0.80
Occupation and pancreatic cancer in Spain: a case-control study based on job titles. PANKRAS II Study Group. Int J Epidemiol (2000) 0.78
Comparison between diagnoses of cancers of the stomach, colon, rectum, gall-bladder, liver and pancreas on death certificates and at autopsy in Trieste, 1970-84. IARC Sci Publ (1991) 0.77
[The search of risk factors for pancreatic cancer: practice, patience and paradigms]. Gastroenterol Hepatol (1997) 0.75
Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group. J Epidemiol Community Health (1999) 4.43
Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg (1990) 3.41
How inbreeding affects productivity in Europe. Nature (2001) 3.18
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy. Gut (2010) 2.98
Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch (2001) 2.73
Vectorial targeting of apical and basolateral plasma membrane proteins in a human adenocarcinoma epithelial cell line. Proc Natl Acad Sci U S A (1989) 2.36
Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol (1999) 2.32
Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology (2000) 2.22
Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol (1997) 2.19
Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. J Natl Cancer Inst (1991) 2.19
Terminal cancer. duration and prediction of survival time. Eur J Cancer (2000) 2.13
Incomplete overlapping of biological, clinical, and environmental information in molecular epidemiological studies: a variety of causes and a cascade of consequences. J Epidemiol Community Health (2002) 2.13
[The use of human gamma globulin in the treatment of common variable immunodeficiency]. Med Clin (Barc) (1995) 2.04
Inferring ancestral origin using a single multiplex assay of ancestry-informative marker SNPs. Forensic Sci Int Genet (2007) 2.03
Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut (2005) 1.87
Improving strategies for detecting genetic patterns of disease susceptibility in association studies. Stat Med (2008) 1.86
Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int J Cancer (1994) 1.82
MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. Gastroenterology (1995) 1.75
Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol (1999) 1.74
Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature. AIDS (1991) 1.74
Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. Br J Surg (1995) 1.67
Myofibroblast proliferation, fibrosis, and defective pancreatic repair induced by cyclosporin in rats. Gut (1999) 1.66
Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells. J Exp Med (1987) 1.65
Basic molecular genetics for epidemiologists. J Epidemiol Community Health (2003) 1.62
Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients. Aliment Pharmacol Ther (2009) 1.62
Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation. Cancer Res (1986) 1.60
Derangement of mucosal barrier function by bacteria colonizing the rat colonic mucosa. Eur J Clin Invest (1998) 1.60
Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology (1999) 1.59
Induction of chronic pancreatic disease by trinitrobenzene sulfonic acid infusion into rat pancreatic ducts. Pancreas (1996) 1.59
Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest (1993) 1.57
VCAM-1, but not ICAM-1 or MAdCAM-1, immunoblockade ameliorates DSS-induced colitis in mice. Lab Invest (2000) 1.54
A brief dementia screener suitable for use by non-specialists in resource poor settings--the cross-cultural derivation and validation of the brief Community Screening Instrument for Dementia. Int J Geriatr Psychiatry (2010) 1.53
Typing of mitochondrial DNA coding region SNPs of forensic and anthropological interest using SNaPshot minisequencing. Forensic Sci Int (2004) 1.52
Diagnostic certainty and potential for misclassification in exocrine pancreatic cancer. PANKRAS I Project Investigations. J Clin Epidemiol (1994) 1.50
Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody. J Exp Med (1984) 1.48
Role of Helicobacter pylori in stomach cancer after partial gastrectomy for benign ulcer disease. Rev Esp Enferm Dig (2005) 1.47
Role of intestinal microflora in chronic inflammation and ulceration of the rat colon. Gut (1994) 1.47
Influence of dose-rate on inflammatory damage and adhesion molecule expression after abdominal radiation in the rat. Int J Radiat Oncol Biol Phys (1999) 1.46
New vectors for combinatorial deletions in yeast chromosomes and for gap-repair cloning using 'split-marker' recombination. Yeast (1996) 1.44
Parosteal osteoma of the iliac bone. Skeletal Radiol (1998) 1.44
Clinical and serologic study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Bull Pan Am Health Organ (1987) 1.41
[CD4+ lymphocytes in patients with a Leishmania-HIV coinfection]. Med Clin (Barc) (1995) 1.41
Influence of "diagnostic delay" upon cancer survival: an analysis of five tumour sites. J Epidemiol Community Health (1991) 1.41
Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations. J Cell Sci (1993) 1.40
Pseudomitochondrial genome haunts disease studies. J Med Genet (2008) 1.40
A multicenter, randomized, double-blind study comparing once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of active duodenal ulcer. Hepatogastroenterology (1989) 1.39
Influence of nutrition, thyroid hormones, and rectal temperature on in-hospital mortality of elderly patients with acute illness. Am J Clin Nutr (1995) 1.39
[Extrabronchial small-cell carcinoma: apropos 6 cases]. Med Clin (Barc) (1993) 1.39
A multicenter, randomized, double-blind study comparing a daily bedtime administration of famotidine and ranitidine in short-term treatment of active duodenal ulcer. Digestion (1989) 1.38
Occurrence, trends and environment etiology of pancreatic cancer. Scand J Work Environ Health (1998) 1.38
[Thrombocytopenia onset in acute episodes of pancreatitis]. Med Clin (Barc) (1995) 1.38
Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer. Proc Natl Acad Sci U S A (2006) 1.36
Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut (1990) 1.34
Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies. J Invest Dermatol (1988) 1.34
Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines. Gastroenterology (1994) 1.34
Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer. Ann Oncol (2011) 1.33
Occupation and bladder cancer in a hospital-based case-control study in Spain. Occup Environ Med (2007) 1.32
Dengue hemorrhagic fever in Cuba, 1981: rapid diagnosis of the etiologic agent. Bull Pan Am Health Organ (1983) 1.32
Normal human pancreas cultures display functional ductal characteristics. Lab Invest (1994) 1.29
Characterization of a mucin cDNA clone isolated from HT-29 mucus-secreting cells. The 3' end of MUC5AC? J Biol Chem (1995) 1.29
Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients. J Med Genet (2008) 1.28
Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33. J Clin Oncol (1990) 1.28
Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. N Engl J Med (1983) 1.26
Cancer survival and the duration of symptoms. An analysis of possible forms of the risk function. ISDS II Project Investigators. Eur J Cancer (1994) 1.25
Biomarkers of exposure to polycyclic aromatic hydrocarbons from environmental air pollution. Occup Environ Med (2004) 1.25
Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues. Cancer Res (1985) 1.24
Artificial recombination in forensic mtDNA population databases. Int J Legal Med (2004) 1.24
Delayed haemolytic transfusion reaction due to anti-M antibody. Br J Haematol (1998) 1.23
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial. Ann Oncol (2005) 1.21
Stimulation of transforming growth factor beta1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis. Gastroenterology (1998) 1.20
Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. Am J Pathol (1992) 1.20
Incrimination of anaerobic bacteria in the induction of experimental colitis. Am J Physiol (1997) 1.20
Kinetic and mechanical basis of rolling through an integrin and novel Ca2+-dependent rolling and Mg2+-dependent firm adhesion modalities for the alpha 4 beta 7-MAdCAM-1 interaction. Biochemistry (2001) 1.20
Coding region mitochondrial DNA SNPs: targeting East Asian and Native American haplogroups. Forensic Sci Int Genet (2006) 1.19
Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. Gastroenterology (1994) 1.18
A bidirectional corridor in the Sahel-Sudan belt and the distinctive features of the Chad Basin populations: a history revealed by the mitochondrial DNA genome. Ann Hum Genet (2007) 1.18